Security
DaVita Inc. · DVA
DVANYSECommon stockCurrentCIK 927066Updated Oct 30, 2026
DVA price & chart
Loading TradingView…
NYSE:DVA on TradingView ↗About the company
DaVita (NYSE: DVA) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for 25 years. DaVita cares for patients at every stage and setting along their kidney health journey - from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home.
In the news
DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering News provided by DaVita May 20, 2025, 16:42 ET Share this article Share to X Share this article Share to X DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA ) ("DaVita") announced today the upsize and pricing of ↗
DaVita Inc. Announces Offering of $750 Million Senior Notes News provided by DaVita May 20, 2025, 08:51 ET Share this article Share to X Share this article Share to X DENVER , May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA ) ("DaVita") announced today that it has commenced a private offering (t ↗
Seeking Alpha
DaVita outlines $2.175B-$2.25B 2026 adjusted operating income outlook as IKC target rises to at least $65M ↗
DaVita Inc. (DVA) Q3 2026 Earnings Call Transcript ↗
DaVita Non-GAAP EPS of $3.82 beats by $0.25, revenue of $3.57B beats by $50M ↗
SEC disclosures
DAVITA INC. files 8-K: Material Event ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
11-K filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 17,555,892,000Source | 17,503,737,000Source | 17,709,489,000Source | 17,492,958,000Source | 17,025,572,000Source | 17,499,365,000Source | 17,119,030,000Source | 17,430,935,000Source | 17,480,103,000Source | 17,285,268,000Source | 16,893,578,000Source | 16,928,252,000Source |
| Property, Plant and Equipment, NetUSD | 2,853,343,000Source | 2,939,620,000Source | 2,749,308,000Source | 2,854,468,000Source | 2,982,222,000Source | 2,754,754,000Source | 2,901,056,000Source | 3,026,170,000Source | 2,812,966,000Source | 2,940,916,000Source | 3,073,533,000Source | 3,256,397,000Source |
| GoodwillUSD | 7,543,878,000Source | 7,227,630,000Source | 7,590,966,000Source | 7,465,769,000Source | 7,201,399,000Source | 7,582,313,000Source | 7,415,560,000Source | 7,229,702,000Source | 7,545,095,000Source | 7,375,216,000Source | 7,112,560,000Source | 7,076,610,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 219,673,000Source | 197,854,000Source | 228,817,000Source | 211,687,000Source | 191,483,000Source | 229,020,000Source | 205,263,000Source | 201,433,000Source | 222,125,000Source | 197,431,000Source | 203,224,000Source | 182,687,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 705,960,000Source | 1,070,775,000Source | 668,963,000Source | 708,417,000Source | 416,493,000Source | 644,243,000Source | 438,780,000Source | 345,131,000Source | 676,438,000Source | 794,933,000Source | 380,063,000Source | 244,086,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,333,319,000Source | 2,267,365,000Source | 2,467,056,000Source | 2,441,259,000Source | 2,303,119,000Source | 2,459,355,000Source | 2,321,818,000Source | 2,594,675,000Source | 2,414,690,000Source | 2,146,975,000Source | 1,986,856,000Source | 2,132,070,000Source |
| Inventory, NetUSD | 139,092,000Source | 128,999,000Source | 151,535,000Source | 146,295,000Source | 126,765,000Source | 141,613,000Source | 150,522,000Source | 145,808,000Source | 160,627,000Source | 134,559,000Source | 143,105,000Source | 109,122,000Source |
| Assets, CurrentUSD | 4,111,826,000Source | 4,037,000,000Source | 4,189,639,000Source | 4,087,828,000Source | 3,466,925,000Source | 4,062,683,000Source | 3,636,188,000Source | 3,683,753,000Source | 4,058,003,000Source | 3,746,072,000Source | 3,137,906,000Source | 3,155,292,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 160,968,000Source | 96,989,000Source | 149,113,000Source | 110,334,000Source | 83,106,000Source | 159,576,000Source | 129,967,000Source | 105,479,000Source | 156,285,000Source | 122,948,000Source | 102,645,000Source | 78,839,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,323,123,000Source | 2,418,350,000Source | 2,430,055,000Source | 2,338,599,000Source | 2,457,565,000Source | 2,396,698,000Source | 2,360,829,000Source | 2,487,158,000Source | 2,397,179,000Source | 2,393,558,000Source | 2,501,364,000Source | 2,666,242,000Source |
| Other Assets, NoncurrentUSD | 204,479,000Source | 218,956,000Source | 298,538,000Source | 192,749,000Source | 240,490,000Source | 266,987,000Source | 238,933,000Source | 262,449,000Source | 246,520,000Source | 261,731,000Source | 271,253,000Source | 315,587,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 16,215,170,000Source | 15,284,063,000Source | 16,630,051,000Source | 15,939,935,000Source | 14,600,716,000Source | 16,451,199,000Source | 15,459,061,000Source | 14,794,948,000Source | 16,321,665,000Source | 15,193,917,000Source | 14,150,228,000Source | 14,703,452,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 91,000Source | 90,000Source | 69,000Source | 91,000Source | 90,000Source | 69,000Source | 91,000Source | 90,000Source | 69,000Source | 90,000Source | 89,000Source | 90,000Source |
| Retained Earnings (Accumulated Deficit)USD | 2,047,216,000Source | 1,275,301,000Source | 81,233,000Source | 1,896,884,000Source | 1,060,613,000Source | -179,242,000Source | 1,697,547,000Source | 837,937,000Source | -328,428,000Source | 1,534,630,000Source | 598,288,000Source | 174,487,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -116,160,000Source | -162,334,000Source | -58,551,000Source | -137,838,000Source | -195,090,000Source | -86,959,000Source | -226,968,000Source | -100,115,000Source | -122,783,000Source | -310,796,000Source | -52,084,000Source | -69,186,000Source |
| Stockholders' Equity Attributable to ParentUSD | -571,874,000Source | 386,715,000Source | -765,096,000Source | -369,633,000Source | 632,900,000Source | -755,496,000Source | -267,101,000Source | 925,997,000Source | -651,082,000Source | 121,122,000Source | 1,056,097,000Source | 712,326,000Source |
| Additional Paid in Capital, Common StockUSD | 401,785,000Source | 295,637,000Source | 0Source | 356,884,000Source | 383,235,000Source | 0Source | 299,467,000Source | 428,202,000Source | 0Source | 286,270,000Source | 509,804,000Source | 606,935,000Source |
| Liabilities and EquityUSD | 17,555,892,000Source | 17,503,737,000Source | 17,709,489,000Source | 17,492,958,000Source | 17,025,572,000Source | 17,499,365,000Source | 17,119,030,000Source | 17,430,935,000Source | 17,480,103,000Source | 17,285,268,000Source | 16,893,578,000Source | 16,928,252,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,017,128,000Source | 2,943,986,000Source | 2,855,432,000Source | 2,933,540,000Source | 2,994,790,000Source | 2,867,459,000Source | 2,906,782,000Source | 2,583,101,000Source | 3,141,634,000Source | 2,973,410,000Source | 2,642,214,000Source | 2,619,747,000Source |
| Operating Lease, Liability, CurrentUSD | 432,015,000Source | 404,540,000Source | 439,488,000Source | 429,252,000Source | 404,820,000Source | 432,219,000Source | 420,506,000Source | 401,371,000Source | 425,484,000Source | 410,411,000Source | 394,399,000Source | 395,401,000Source |
| Accounts Payable, CurrentUSD | 655,598,000Source | 488,244,000Source | 715,872,000Source | 594,403,000Source | 493,534,000Source | 691,256,000Source | 596,137,000Source | 489,883,000Source | 696,148,000Source | 547,200,000Source | 514,533,000Source | 479,780,000Source |
| Operating Lease, Liability, NoncurrentUSD | 2,099,531,000Source | 2,237,135,000Source | 2,185,973,000Source | 2,124,875,000Source | 2,281,372,000Source | 2,162,372,000Source | 2,161,439,000Source | 2,311,902,000Source | 2,175,658,000Source | 2,209,655,000Source | 2,330,389,000Source | 2,503,068,000Source |
| Deferred Income Tax Liabilities, NetUSD | 742,453,000Source | 659,581,000Source | 825,719,000Source | 646,229,000Source | 693,982,000Source | 818,918,000Source | 664,580,000Source | 719,545,000Source | 756,869,000Source | 665,361,000Source | 726,217,000Source | 782,787,000Source |
| Other Liabilities, NoncurrentUSD | 172,195,000Source | 183,030,000Source | 99,091,000Source | 156,486,000Source | 179,010,000Source | 88,853,000Source | 166,515,000Source | 179,806,000Source | 83,516,000Source | 169,588,000Source | 183,074,000Source | 105,233,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 267,642,000Source | 199,948,000Source | 283,118,000Source | 261,666,000Source | 217,116,000Source | 279,157,000Source | 260,549,000Source | 206,516,000Source | 277,354,000Source | 274,746,000Source | 187,965,000Source | 163,566,000Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 687,127,000Source | 619,108,000Source | 691,780,000Source | 755,081,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 1,644,954,000Source | 1,633,011,000Source | 1,561,416,000Source | 1,660,990,000Source | 1,574,840,000Source | 1,524,505,000Source | 1,666,521,000Source | 1,503,474,000Source | 1,532,166,000Source | 1,695,483,000Source | 1,499,288,000Source | 1,348,908,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | 240,249,000Source | 295,760,000Source | 343,223,000Source | 275,220,000Source | 275,035,000Source | 232,216,000Source | 1,078,716,000Source | 1,250,737,000Source | 956,978,000Source | 781,643,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 177,490,000Source | 187,014,000Source | 167,808,000Source | 174,704,000Source | 177,829,000Source | 176,451,000Source | 708,252,000Source | 716,396,000Source | 736,474,000Source | 721,133,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 28,160,000Source | 29,759,000Source | 139,953,000Source | 102,788,000Source | 112,375,000Source | 95,427,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 29,751,000Source | 155,276,000Source | 210,632,000Source | 29,766,000Source | -172,361,000Source | 148,394,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -20,277,000Source | 14,772,000Source | 19,950,000Source | -17,942,000Source | 32,132,000Source | 757,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -23,774,000Source | 46,195,000Source | 128,303,000Source | 1,699,000Source | 26,890,000Source | 87,481,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 54,798,000Source | 4,335,000Source | 86,574,000Source | -57,840,000Source | -39,354,000Source | -75,669,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 320,831,000Source | 180,009,000Source | 1,886,500,000Source | 2,022,038,000Source | 2,059,031,000Source | 1,564,570,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 117,468,000Source | 246,068,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -139,091,000Source | -162,138,000Source | -654,949,000Source | -771,429,000Source | -771,800,000Source | -630,347,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 102,018,000Source | 143,258,000Source | 575,864,000Source | 555,443,000Source | 567,985,000Source | 603,429,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 63,155,000Source | 30,214,000Source | 35,291,000Source | 134,040,000Source | — | — |
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 196,371,000Source | 510,161,000Source | 1,308,366,000Source | 1,385,932,000Source | 272,219,000Source | 802,228,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -213,343,000Source | -382,540,000Source | -1,374,780,000Source | -816,937,000Source | -1,170,495,000Source | -1,121,128,000Source |
| Payments of Ordinary Dividends, Common StockUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -31,344,000Source | -355,252,000Source | -122,078,000Source | 415,191,000Source | 125,645,000Source | -215,971,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 795,414,000Source | 1,158,644,000Source | 751,858,000Source | 796,959,000Source | 726,403,000Source | 524,573,000Source | 757,747,000Source | 879,825,000Source | 464,634,000Source | 338,989,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 515,497,000Source | 423,360,000Source | 387,661,000Source | 350,999,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 176,688,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | 40,002,000Source | 35,266,000Source | 24,600,000Source | 17,772,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 7,096,000Source | 7,464,000Source | 8,969,000Source | 11,469,000Source |
| Depreciation, Amortization and Accretion, NetUSD | — | — | — | — | — | — | 177,829,000Source | 176,451,000Source | 715,348,000Source | 723,860,000Source | 745,443,000Source | 732,602,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | — | — | — | — | — | — | 109,466,000Source | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 414,373,000Source | 393,534,000Source | 423,458,000Source | 412,805,000Source | 421,914,000Source | 374,090,000Source | 1,673,630,000Source | 1,538,341,000Source | 1,473,984,000Source | 1,355,197,000Source |
| GoodwillUSD | — | — | 7,543,878,000Source | 7,227,630,000Source | 7,590,966,000Source | 7,465,769,000Source | 7,582,313,000Source | 7,415,560,000Source | 7,545,095,000Source | 7,375,216,000Source | 7,112,560,000Source | 7,076,610,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 26,083,000Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 26,083,000Source | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | 721,803,000Source | 936,342,000Source | 691,535,000Source | 546,948,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 1,053,716,000Source | 1,250,737,000Source | 956,978,000Source | 768,191,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 25,000,000Source | 0Source | 0Source | 13,452,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | 25,000,000Source | 0Source | 0Source | 13,452,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 10,162,000Source | 3,711,000Source | 8,184,000Source | 7,364,000Source | 8,344,000Source | 5,609,000Source | 33,000,000Source | 26,189,000Source | 27,864,000Source | 26,520,000Source |
| Income Tax Expense (Benefit)USD | — | — | 68,554,000Source | 77,674,000Source | 91,787,000Source | 93,708,000Source | 66,199,000Source | 54,117,000Source | 293,107,000Source | 279,656,000Source | 220,116,000Source | 198,087,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 150,332,000Source | 214,688,000Source | 265,397,000Source | 199,337,000Source | 197,530,000Source | 162,917,000Source | 746,803,000Source | 936,342,000Source | 691,535,000Source | 560,400,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 89,917,000Source | 81,072,000Source | 77,826,000Source | 75,883,000Source | 77,505,000Source | 69,299,000Source | 331,913,000Source | 314,395,000Source | 265,443,000Source | 221,243,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 570,303,000Source | 557,591,000Source | 556,844,000Source | 552,194,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -41,257,000Source | -16,780,000Source | 8,300,000Source | -22,851,000Source | 4,473,000Source | -17,549,000Source | -102,688,000Source | -69,808,000Source | -19,177,000Source | -15,765,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | 2,882,000Source | 6,411,000Source | 53,819,000Source | — | — | — |
| Proceeds from Contributions from AffiliatesUSD | — | — | — | — | — | — | 4,049,000Source | 2,169,000Source | 7,078,000Source | 14,499,000Source | 14,773,000Source | 14,797,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | 1,263,179,000Source | 633,189,000Source | 5,612,280,000Source | 6,624,310,000Source | 2,468,341,000Source | 2,393,116,000Source |
| Proceeds from Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | 3,794,000Source | 860,000Source | 50,962,000Source | 3,673,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 3,420,227,000Source | 3,263,590,000Source | 3,554,084,000Source | 3,379,526,000Source | 3,415,548,000Source | 3,223,529,000Source | 13,643,069,000Source | 12,815,550,000Source | 12,140,147,000Source | 11,609,894,000Source |
| Operating Income (Loss)USD | — | — | 505,767,000Source | 534,878,000Source | 579,001,000Source | 537,841,000Source | 481,892,000Source | 438,937,000Source | 2,043,615,000Source | 2,090,483,000Source | 1,602,784,000Source | 1,339,062,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -41,257,000Source | -16,780,000Source | 8,300,000Source | -22,851,000Source | 4,473,000Source | -17,549,000Source | -102,688,000Source | -69,808,000Source | -19,177,000Source | -15,765,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | 308,803,000Source | 373,434,000Source | 435,010,000Source | 368,928,000Source | 341,234,000Source | 286,333,000Source | 1,346,823,000Source | 1,530,393,000Source | 1,177,094,000Source | 966,278,000Source |
| Income Tax Expense (Benefit)USD | — | — | 68,554,000Source | 77,674,000Source | 91,787,000Source | 93,708,000Source | 66,199,000Source | 54,117,000Source | 293,107,000Source | 279,656,000Source | 220,116,000Source | 198,087,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 89,917,000Source | 81,072,000Source | 77,826,000Source | 75,883,000Source | 77,505,000Source | 69,299,000Source | 331,913,000Source | 314,395,000Source | 265,443,000Source | 221,243,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | 150,332,000Source | 214,688,000Source | 265,397,000Source | 199,337,000Source | 197,530,000Source | 162,917,000Source | 746,803,000Source | 936,342,000Source | 691,535,000Source | 560,400,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 2.09Source | 2.56Source | 4.1Source | 2.62Source | 2.93Source | 2.05Source | 10.06Source | 11.02Source | 7.62Source | 6.03Source |
| Earnings Per Share, DilutedUSD per share | — | — | 2.04Source | 2.5Source | 4.02Source | 2.58Source | 2.87Source | 2Source | 9.84Source | 10.73Source | 7.42Source | 5.85Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 72,075,000Source | 83,721,000Source | 64,781,000Source | 75,943,000Source | 67,390,000Source | 79,368,000Source | 74,227,000Source | 84,991,000Source | 90,790,000Source | 92,992,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 73,769,000Source | 85,795,000Source | 66,092,000Source | 77,362,000Source | 68,875,000Source | 81,275,000Source | 75,885,000Source | 87,274,000Source | 93,182,000Source | 95,834,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | 7,096,000Source | 7,464,000Source | 8,969,000Source | 11,469,000Source |
| Costs and ExpensesUSD | — | — | 2,914,460,000Source | 2,728,712,000Source | 2,975,083,000Source | 2,841,685,000Source | 2,933,656,000Source | 2,784,592,000Source | 11,599,454,000Source | 10,725,067,000Source | 10,537,363,000Source | 10,270,832,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 206,538,000Source | 337,446,000Source | 259,448,000Source | 273,778,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 177,490,000Source | 187,014,000Source | 167,808,000Source | 174,704,000Source | 177,829,000Source | 176,451,000Source | 715,348,000Source | 723,860,000Source | 745,443,000Source | 732,602,000Source |
| General and Administrative ExpenseUSD | — | — | 414,373,000Source | 393,534,000Source | 423,458,000Source | 412,805,000Source | 421,914,000Source | 374,090,000Source | 1,673,630,000Source | 1,538,341,000Source | 1,473,984,000Source | 1,355,197,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source | 26,083,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | 721,803,000Source | 936,342,000Source | 691,535,000Source | 546,948,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | 1,224,860,000Source | 1,374,571,000Source | 1,100,420,000Source | 926,604,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 1,053,716,000Source | 1,250,737,000Source | 956,978,000Source | 768,191,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | — | — | — | — | — | — | 9.72Source | 11.02Source | 7.62Source | 5.88Source |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | — | — | — | — | — | — | 9.51Source | 10.73Source | 7.42Source | 5.71Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | 25,000,000Source | 0Source | 0Source | 13,452,000Source |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | — | — | — | — | — | — | 25,000,000Source | 0Source | 0Source | 13,452,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | 10,162,000Source | 3,711,000Source | 8,184,000Source | 7,364,000Source | 8,344,000Source | 5,609,000Source | 33,000,000Source | 26,189,000Source | 27,864,000Source | 26,520,000Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | — | — | 539,924,000Source | 435,203,000Source | 373,951,000Source | 339,247,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 570,303,000Source | 557,591,000Source | 556,844,000Source | 552,194,000Source |
| Other IncomeUSD | — | — | 122,137,000Source | 125,029,000Source | 187,707,000Source | 172,655,000Source | 142,751,000Source | 120,536,000Source | 635,883,000Source | 555,175,000Source | 565,206,000Source | 433,430,000Source |
Filing attachments
dva93026ex991.htm · 8-K · 2026-10-29
Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 3rd Quarter 2026 Results Denver, Colorado, October 29, 2026 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2026. Financial and operating highlights for the quarter ended September 30, 2026: • Consolidated revenues were $3.578 billion. • Operating income was $499 million and adjusted operating income was $561 million. • Diluted earnings per share was $3.40 and adjuste…
Read attachment ↗dva63026ex991.htm · 8-K · 2026-08-04
EX-99.1 2 dva63026ex991.htm EX-99.1 Document Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 2nd Quarter 2026 Results Denver, Colorado, August 4, 2026 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2026. “Thanks to the outstanding efforts of our teammates, we had another positive quarter for both patient outcomes and financial results,” said Javier Rodriguez, CEO of DaVita Inc. “As we look to the rest of the year, we…
Read attachment ↗dva33126ex991.htm · 8-K · 2026-05-05
EX-99.1 2 dva33126ex991.htm EX-99.1 Document Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 1st Quarter 2026 Results Denver, Colorado, May 5, 2026 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2026. “DaVita’s foundation is clinical excellence, driven by operating rigor that produces durable results,” said Javier Rodriguez, CEO of DaVita Inc. “We have consistently delivered exceptional clinical outcomes and strong …
Read attachment ↗dva-123125ex991.htm · 8-K · 2026-02-02
Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 4th Quarter 2025 Results Denver, Colorado, February 2, 2026 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025. “Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a challenging environment,” said Javier Rodriguez, CEO of Da…
Read attachment ↗dva-93025ex991.htm · 8-K · 2025-10-29
EX-99.1 2 dva-93025ex991.htm EX-99.1 Document Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 3rd Quarter 2025 Results Denver, Colorado, October 29, 2025 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025. “Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance,” said Javier Rodriguez, CEO of DaVita. “Our consistent focus on providing outstanding …
Read attachment ↗dva-63025ex991.htm · 8-K · 2025-08-05
EX-99.1 2 dva-63025ex991.htm EX-99.1 Document Contact: Investor Relations DaVita Inc. ir@davita.com DaVita Inc. 2nd Quarter 2025 Results Denver, Colorado, August 5, 2025 - DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2025. “We’re reporting another solid quarter, fueled by our unwavering focus on patient care,” said Javier Rodriguez, CEO of DaVita Inc. “We continued to deliver exceptional clinical outcomes for our patients, fostered a …
Read attachment ↗